Alterio Ronald Vincent 4
4 · BLONDER TONGUE LABORATORIES INC · Filed Apr 25, 2022
Insider Transaction Report
Form 4
Alterio Ronald Vincent
VP-Engineering, CTO
Transactions
- Award
Common Stock, par value $0.001
2022-04-22$0.69/sh+836$577→ 82,782 total - Award
Common Stock, par value $0.001
2022-04-22$0.69/sh+5,393$3,721→ 88,175 total
Footnotes (2)
- [F1]Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).
- [F2]Pursuant to the participation in the Second Amended and Restated Executive Stock Purchase Plan between the reporting person and the issuer, on the date on which a portion of the reporting person's net cash compensation has been reduced, the issuer issued the number of shares indicated. The number of shares of common stock issued represents the quotient of (i) the portion of the net cash compensation reduction divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).